121 related articles for article (PubMed ID: 19944004)
1. Sublingual immunotherapy: administration, dosages, use.
Frati F; La Grutta S; Bernardini R; Zampogna S; Scurati S; Puccinelli P; Riario-Sforza GG; Incorvaia C
Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):13-6. PubMed ID: 19944004
[TBL] [Abstract][Full Text] [Related]
2. Optimal duration of SLIT.
Caffarelli C; Cardinale F; Povesi C; Chinellato I; Sterpeto Loffredo M
Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):17-22. PubMed ID: 19944005
[TBL] [Abstract][Full Text] [Related]
3. The future of sublingual immunotherapy.
Marcucci F; Duse M; Frati F; Incorvaia C; Marseglia GL; La Rosa M
Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):31-3. PubMed ID: 19944008
[TBL] [Abstract][Full Text] [Related]
4. An evidence based overview of sublingual immunotherapy in children.
Scala G; Di Rienzo Businco A; Ciccarelli A; Tripodi S
Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):23-6. PubMed ID: 19944006
[TBL] [Abstract][Full Text] [Related]
5. Administration regimens for sublingual immunotherapy to pollen allergens: what do we know?
Lombardi C; Incorvaia C; Braga M; Senna G; Canonica GW; Passalacqua G
Allergy; 2009 Jun; 64(6):849-54. PubMed ID: 19392995
[TBL] [Abstract][Full Text] [Related]
6. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
[TBL] [Abstract][Full Text] [Related]
8. Oral and sublingual immunotherapy: general aspects and critical considerations.
Passalacqua G; Venturi S; Zoccali P; Braido F; Ghiazza P; Mincarini M; Canonica GW
Wien Med Wochenschr; 1999; 149(14-15):433-7. PubMed ID: 10584288
[TBL] [Abstract][Full Text] [Related]
9. Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units.
Larenas-Linnemann D; Esch R; Plunkett G; Brown S; Maddox D; Barnes C; Constable D
Ann Allergy Asthma Immunol; 2011 Nov; 107(5):448-458.e3. PubMed ID: 22018618
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of ultra-rush induction, less than one hour, of sublingual immunotherapy in children.
Tripodi S; Di Rienzo Businco A; Benincori N; Scala G; Pingitore G
Int Arch Allergy Immunol; 2006; 139(2):149-52. PubMed ID: 16374025
[TBL] [Abstract][Full Text] [Related]
11. A bright future for sublingual immunotherapy--contra.
Kleine-Tebbe J
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):242-50; discussion 250-2. PubMed ID: 17393746
[TBL] [Abstract][Full Text] [Related]
12. The history of sublingual immunotherapy.
Pajno GB; Barberi S
Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):1-3. PubMed ID: 19944001
[TBL] [Abstract][Full Text] [Related]
13. Sublingual immunotherapy: the optimism and the issues.
Pajno GB
J Allergy Clin Immunol; 2007 Apr; 119(4):796-801. PubMed ID: 17306355
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
[TBL] [Abstract][Full Text] [Related]
15. Immune mechanisms of allergen-specific sublingual immunotherapy.
Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
[TBL] [Abstract][Full Text] [Related]
16. Multiallergen immunotherapy for allergic rhinitis and asthma.
Nelson HS
J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
[TBL] [Abstract][Full Text] [Related]
17. Sublingual immunotherapy: from safety to mechanism of action.
Marcucci F; Sensi L; Allocca G; Chiarello F; Palleri P; Ugolini E; Di Rienzo A; Castellani S; Incorvaia C; Di Cara G; Puccinelli P; Frati F
Eur Ann Allergy Clin Immunol; 2007 Mar; 39(3):101-3. PubMed ID: 17465282
[TBL] [Abstract][Full Text] [Related]
18. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial.
Kleine-Tebbe J; Ribel M; Herold DA
Allergy; 2006 Feb; 61(2):181-4. PubMed ID: 16409193
[TBL] [Abstract][Full Text] [Related]
19. Sublingual Immunotherapy: Past, present, paradigm for the future? A review of the literature.
Leatherman BD; Owen S; Parker M; Chadwick S; Fornadley JA; Colson D; Fass P
Otolaryngol Head Neck Surg; 2007 Mar; 136(3 Suppl):S1-20. PubMed ID: 17321336
[TBL] [Abstract][Full Text] [Related]
20. Quality of life outcomes with sublingual immunotherapy.
Wise SK; Woody J; Koepp S; Schlosser RJ
Am J Otolaryngol; 2009; 30(5):305-11. PubMed ID: 19720247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
